Covid variant XBB.1.16 driving up cases in India, know its symptoms

Amid the spike in cases, the Union Health Ministry has alerted all the state governments to be prepared for rise in Covid cases



BS Web Team New Delhi

Listen to This Article

India has reported over 10,000 cases of Coronavirus in a single day, making it the highest single-day spike since September 2022. It is believed that the current Covid-19 surge is being led by XBB.1.16, also known as the Arcturus variant. Many experts are of the opinion that the next few weeks could be important.

Amid the spike in cases, the Union Health Ministry also held a two-day nationwide mock drill across hospitals to review preparedness.

Dr. Dhiren Gupta, a senior pediatrician at Sir Ganga Ram Hospital, told ANI, that the XBB.1.16 variant is the primary cause behind the rise in cases among children and adults. He further added, "This variant is showing immune escape and is able to evade the immune system. It is infecting those who had the Covid infection during the previous waves and also teenagers and adults who have been vaccinated."

Symptoms of XBB.1.16 variant

Some of the common symptoms of this variant include sore throat, upper respiratory illnesses like headache, and a blocked nose. Some other symptoms also include muscle pain and fever pain, Apollo Hospitals said on its website. It also added that this new variant can also disrupt your digestive system resulting in diarrhoea.

According to several media reports, a new symptom of the XBB.1.16 variant is being widely discussed. A tweet by a senior Pediatrician Vipin M. Vashishtha is being referred to. "For the last 2 days, I have started getting pediatric Covid cases once again after a gap of six months! An infantile phenotype seems emerging—treated infants with high fever, cold & cough, & non-purulent, itchy conjunctivitis with sticky eyes, not seen in earlier waves," the expert tweeted. 

The new variant is also believed to be highly transmissible, however, it is not as lethal as previous strains. Dr. Vashishtha also said in another tweet, '"All eyes should be on India! If XBB.1.16 aka 'Arcturus' could succeed to wade through the ‘sturdy’ population immunity of Indians that successfully resisted the onslaught of variants like BA.2.75, BA.5, BQs, XBB.1.5, then the whole world must be seriously worried!

According to a report by Economic Times, Dr. S K Nakra, the Consultant General Pediatrician at Madhukar Rainbow Children's Hospital, told ANI in an interview that conjunctivitis has also been reported in some Covid positive cases. 

The World Health Organization (WHO) is also maintaining a close watch on this new Covid sub-variant, which was added to the list of variants under monitoring on March 22, 2023. XBB.1.16 is a recombinant of BA.2.10.1 and BA.2.75, said WHO.

Also Read

Apollo focusing on prevention to tackle the NCD crisis: Preetha Reddy

Centre tells states to conduct Covid mock drills in hospitals as cases rise

Rising Covid cases in India a non-event for markets for now: Analysts

The health operator: Meet Sangita Reddy, Joint MD of Apollo Hospitals

India now has 20,000 tonnes per day Oxygen capacity. 90% of it lying idle

Endemic is the new normal as daily Covid cases top 10,000 in India

Expert disagrees with Centre's claim of Coronavirus becoming an endemic

Delhi govt working on guidelines for school amidst Covid surge: Atishi

Covid-19: Serum Institute of India restarts manufacturing Covishield

As Covid cases spike in India again, IMA lists 3 possible reasons for rise

First Published: Apr 13 2023 | 10:20 PM IST

Explore News